Ultrasonographic studies on the reproductive tract of mares after parturition: effect of involution and uterine fluid on pregnancy rates in mares with normal and delayed first postpartum ovulatory cycles.
During breeding of mares, ultrasonographic detection of uterine fluid accumulations in the first postpartum ovulatory period was associated with significantly decreased pregnancy rates, when compared with rates in control mares (P less than 0.005). The previously gravid uterine horn was recognized as the larger horn, when assessed for size by ultrasonography, for a mean of 21 days (range, 15 to 25 days) after parturition. On the basis of similar measurements obtained during 3 ultrasonographic scans (5-day period), uterine involution was determined to be completed in a mean of 23 days (range, 13 to 29 days). Progestin treatment did not affect uterine size, fluid accumulation, or rate of involution after parturition. However, delaying the first postpartum ovulation with 8 days of progestin treatment significantly improved pregnancy rates (P less than 0.05). More (P less than 0.05) mares became pregnant (23 of 28, 82%) when ovulation occurred after day 15 in the first postpartum ovulatory period, compared with those mares that ovulated before day 15 (6 of 12, 50%). We concluded that ultrasonographic detection of uterine fluid and postpartum progestin treatment can be used to manipulate breeding strategies and to improve pregnancy rates in mares bred during the first postpartum ovulatory period.
McKinnon
A O
AO
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523.
Squires
E L
EL
Harrison
L A
LA
Blach
E L
EL
Shideler
R K
RK
D000818:Animals; D004971:Estrus / Q000187:drug effects / Q000502:physiology*; D005260:Female; D005306:Fertilization; D006736:Horses / Q000502:physiology*; D049590:Postpartum Period / Q000502:physiology*; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D045167:Progesterone Congeners / Q000494:pharmacology; D014204:Trenbolone Acetate / Q000031:analogs & derivatives / Q000494:pharmacology; D014463:Ultrasonography / Q000662:veterinary*; D014590:Uterine Contraction; D014599:Uterus / Q000033:anatomy & histology*
D045167:Progesterone Congeners; C023445:altrenogest; D014204:Trenbolone Acetate